Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation
NCT ID: NCT07273448
Last Updated: 2025-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
100 participants
OBSERVATIONAL
2014-01-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation
NCT07105085
Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
NCT07301853
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation
NCT05448339
Adult-to-Adult Living Donor Liver Transplantation Study
NCT00096733
Effect of Transfusion of Plasma on Endothelial During Liver Transplantation
NCT04107883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABO-Incompatible Living Donor Liver Transplantation Patients
Evaluate the postoperative survival rate and incidence of rejection in patients undergoing ABO-incompatible living donor liver transplantation; analyze the occurrence of secondary endpoint events such as postoperative vascular complications and biliary complications; and explore relevant risk factors affecting prognosis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Complete and intact clinical and follow-up data
Exclusion Criteria
2. Combined other organ transplantation
3. Incomplete clinical data or loss to follow-up
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ru-zhou Cai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ru-zhou Cai
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BFH20251127006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.